Thursday, AstraZeneca Plc ( AZN )  raised its annualized dividend for 2024 by $0.20 to $3.10 per share, underlining the company’s confidence in its performance and cash generation.  The company said the 7% increase takes into account other capital allocation priorities and previously announced acquisitions and business development. Michel Demaré, Chair, AstraZeneca ( AZN ), said: “This uplift is in line with our...

MILAN, April 11 (Reuters) - Activist investor Bluebell Capital Partners is proposing to nominate an outgoing Google executive as candidate for the role of CEO of Telecom Italia (TIM), in a challenge to Pietro Labriola's bid for a second term. In a document presenting Bluebell's vision for TIM, seen by Reuters, it proposed Laurence Lafont, the outgoing vice-president for strategic...

09:03 AM EDT, 04/11/2024 (MT Newswires) -- Western pharmaceutical companies Eli Lilly ( LLY ) , Vertex Pharmaceuticals ( VRTX ) and BeiGene ( BGNE ) are seeking alternative suppliers amid the proposed Biosecure Act in the US that would forbid US firms getting federal grant money from working with four Chinese biotech companies, including WuXi AppTec and WuXi Biologics,...

April 11 (Reuters) - Swiss drugmaker Novartis AG has entered into a licensing deal worth up to $1.01 billion with Arvinas ( ARVN ) to gain access to the U.S. biotech firm's experimental prostate cancer drug, Arvinas ( ARVN ) said on Thursday. Shares of Connecticut-based Arvinas ( ARVN ) rose more than 6% to $39 in premarket trade. The...